These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 3876236)

  • 1. The mucosal defence capacity against proteolytic leukocyte enzymes.
    Tegner H; Fryksmark U; Ohlsson K
    Eur J Respir Dis Suppl; 1985; 139():62-5. PubMed ID: 3876236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rôle of proteases and antiproteases in bronchial secretions.
    Hutchison DC
    Eur J Respir Dis Suppl; 1987; 153():78-85. PubMed ID: 2448162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the role of antileukoprotease in respiratory tract diseases.
    Fryksmark U; Prellner T; Tegner H; Ohlsson K
    Eur J Respir Dis; 1984 Apr; 65(3):201-9. PubMed ID: 6202540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The elastase/alpha 1-proteinase inhibitor balance in the lung. A review.
    Virca GD; Schnebli HP
    Schweiz Med Wochenschr; 1984 Jun; 114(25):895-8. PubMed ID: 6379867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cigarette smoke condensate on alpha 1-antitrypsin, antileukoprotease and granulocyte elastase.
    Ohlsson K; Fryksmark U; Tegner H
    Eur J Clin Invest; 1980 Oct; 10(5):373-9. PubMed ID: 6777171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of granulocyte proteases with inhibitors in pulmonary diseases.
    Ohlsson K; Fryksmark U; Ohlsson M; Tegner H
    Adv Exp Med Biol; 1984; 167():299-312. PubMed ID: 6201045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elastase inhibitors of the respiratory tract.
    Stockley RA; Morrison HM
    Eur Respir J Suppl; 1990 Mar; 9():9s-15s. PubMed ID: 2340054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mucosal defence capacity against proteolytic leukocyte enzymes.
    Fryksmark U; Ohlsson K; Tegner H
    Rhinology; 1983 Mar; 21(1):39-43. PubMed ID: 6687953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
    Kouchi I; Yasuoka S; Ueda Y; Ogura T
    Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antileukoprotease in patients with maxillary sinusitis.
    Fryksmark U; Jannert M; Ohlsson K; Tegner H
    Rhinology; 1985 Sep; 23(3):247-51. PubMed ID: 3851511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileukoprotease, its role in the human lung.
    Kramps JA; Willems LN; Franken C; Dijkman JH
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():83-7. PubMed ID: 3202975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratracheally-instilled antileukoprotease and alpha 1-proteinase inhibitor: effect on human neutrophil elastase-induced experimental emphysema and pulmonary localization.
    Rudolphus A; Kramps JA; Mauve I; Dijkman JH
    Histochem J; 1994 Oct; 26(10):817-24. PubMed ID: 7883591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.
    Ogushi F; Hubbard RC; Vogelmeier C; Fells GA; Crystal RG
    J Clin Invest; 1991 Mar; 87(3):1060-5. PubMed ID: 1999486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI).
    Fritz H
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():79-82. PubMed ID: 3060147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular mass bronchial proteinase inhibitor and alpha 1-proteinase inhibitor in sputum and bronchoalveolar lavage.
    Stockley RA; Morrison HM; Smith S; Tetley T
    Hoppe Seylers Z Physiol Chem; 1984 May; 365(5):587-95. PubMed ID: 6332053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor.
    Ying QL; Simon SR
    Am J Respir Cell Mol Biol; 2000 Oct; 23(4):506-13. PubMed ID: 11017916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental studies on emphysema and chronic bronchial injury.
    Snider GL
    Eur J Respir Dis Suppl; 1986; 146():17-35. PubMed ID: 3536550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor activity against elastolytic enzymes in the bronchial area. A contribution to the pathogenesis of chronic airway obstruction.
    Rasche B
    Z Erkr Atmungsorgane; 1985; 165(1):83-93. PubMed ID: 3851611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of elastase inhibitory activity of alpha 1-proteinase inhibitor and bronchial antileukoprotease: different results using insoluble elastin or synthetic low molecular weight substrates.
    Kramps JA; Morrison HM; Burnett D; Dijkman JH; Stockley RA
    Scand J Clin Lab Invest; 1987 Jun; 47(4):405-10. PubMed ID: 2440098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.